October 19, 2026
Deep Learning for Medical Diagnosis and Prognosis

Deep Learning for Medical Diagnosis and Prognosis

Introduction

Artificial Intelligence (AI) is transforming healthcare by enabling faster, more accurate, and data-driven decisions. Deep learning, a subset of machine learning, has shown great potential in analyzing complex medical data such as medical images and electronic health records (EHRs).

This blog reviews recent research on deep learning for medical diagnosis and prognosis, highlighting key findings, challenges, and future possibilities. It focuses on two research studies: one on Alzheimer’s disease classification using MRI scans and another on early COVID-19 mortality prediction using chest X-rays and electronic health records.

Literature Review Methodology

The selected research papers were published in 2023 in reputed scientific journals. The review focuses on the research problem, algorithms, datasets, experimental methodology, evaluation metrics, results, advantages, limitations, and future scope of each study.

The two studies were selected to compare image-based deep learning with multimodal AI, which combines medical images and structured clinical data.

Review of Selected Research Papers

1. Automated Medical Diagnosis of Alzheimer’s Disease Using an EfficientNet Convolutional Neural Network

Authors: Deevyankar Agarwal, Manuel Álvaro Berbís, Antonio Luna, Vivian Lipari, Julien Brito Ballester, et al.

Journal: Journal of Medical Systems, Springer

Year: 2023

DOI: 10.1007/s10916-023-01941-4

Research Problem

Early and accurate identification of Alzheimer’s disease (AD) is difficult because the anatomical differences between Alzheimer’s disease and mild cognitive impairment can be subtle.

The researchers investigated whether a three-dimensional EfficientNet-B0 Convolutional Neural Network (CNN) could automatically classify MRI scans into three categories:

  • Alzheimer’s disease (AD)
  • Stable mild cognitive impairment (sMCI)
  • Cognitively normal (CN)

Method and Algorithm

The study used EfficientNet-B0, a convolutional neural network designed for efficient image processing. The researchers combined end-to-end learning with transfer learning and evaluated the model using five-fold cross-validation.

MRI preprocessing included bias-field correction, denoising, brain extraction, registration, and spatial normalization. Occlusion sensitivity maps were also used to understand which regions of MRI scans influenced the model’s predictions.

Dataset

The study used data from the following sources:

  • Alzheimer’s Disease Neuroimaging Initiative (ADNI)
  • IXI database
  • Spanish clinical MRI data for external validation

The main dataset contained 458 T1-weighted MRI scans from ADNI, comprising 229 AD cases and 229 sMCI cases. An additional 245 cognitively normal scans were obtained from the IXI database. External validation used MRI data from 22 Spanish patients with AD or MCI.

Evaluation Metrics

The model was evaluated using accuracy, precision, recall or sensitivity, specificity, F1-score, and the Area Under the Receiver Operating Characteristic Curve (ROC-AUC).

Major Results

For the binary classification task of Alzheimer’s disease versus stable mild cognitive impairment, the best testing fold achieved:

  • Accuracy: 93.10%
  • AUC: 93.0%

The testing set contained 58 MRI scans, including 29 AD cases and 29 sMCI cases. The model correctly classified all 29 AD cases and incorrectly classified four of the 29 sMCI cases.

For the three-class classification task, the reported AUC values were:

  • Cognitively normal (CN): 93.0%
  • Alzheimer’s disease (AD): 95.0%
  • Stable mild cognitive impairment (sMCI): 84.0%

External validation using Spanish clinical data achieved 86.36% accuracy, with 19 out of 22 predictions matching the clinical findings.

Advantages

  • Automates Alzheimer’s disease classification using deep learning.
  • Uses three-dimensional MRI information instead of relying only on manually extracted features.
  • Combines end-to-end learning and transfer learning.
  • Includes external validation with clinical data.
  • Uses occlusion sensitivity maps to help interpret model predictions.

Limitations

The study used a relatively limited number of MRI scans for training and testing. Distinguishing Alzheimer’s disease from mild cognitive impairment remains difficult because their anatomical characteristics can be similar. The external validation dataset contained only 22 patients, so larger and more diverse validation studies are needed.

2. Deep Learning Approach for Early Prediction of COVID-19 Mortality Using Chest X-Ray and Electronic Health Records

Authors: Seung Min Baik, Kyung Sook Hong, and Dong Jin Park

Journal: BMC Bioinformatics, Springer Nature

Year: 2023

DOI: 10.1186/s12859-023-05321-0

Research Problem

The second study addresses the challenge of predicting whether a patient with COVID-19 is likely to survive or die at an early stage.

Instead of relying only on chest X-ray images, the researchers combined medical images with electronic health record (EHR) information, including laboratory results, vital signs, and other clinical data. The goal was to improve mortality prediction by combining complementary information from different sources.

Method and Algorithm

The researchers developed an ensemble AI model using multiple machine learning and deep learning techniques.

The main techniques included:

  • Convolutional Neural Networks (CNNs): EfficientNet-B1, EfficientNet-B2, and Inception-ResNet-V2 for analyzing chest X-ray images.
  • Multilayer Perceptron (MLP): For processing structured electronic health record data.
  • XGBoost: For predicting outcomes from clinical data.
  • Random Forest: For analyzing structured patient information.
  • Soft-voting ensemble: For combining predictions from multiple models.

The study also used SHAP (SHapley Additive exPlanations) to identify important clinical features and Grad-CAM (Gradient-weighted Class Activation Mapping) to visualize important regions in chest X-ray images.

Dataset

The study included 304 COVID-19 patients:

  • 68 non-survivors
  • 236 survivors

The model used initial chest X-ray images and EHR information to predict mortality.

Experimental Methodology

The researchers processed chest X-ray images and EHR data separately before combining their predictions through an ensemble model.

CNN models were evaluated using 10-fold validation, while EHR models were evaluated using five-fold validation.

The final ensemble combined the predictions from image-based and clinical-data models to improve mortality prediction.

Evaluation Metrics

The study used the following metrics:

  • Area Under the Receiver Operating Characteristic Curve (AUROC)
  • Accuracy
  • Precision
  • Recall
  • F1-score
  • SHAP and Grad-CAM were additionally used to improve the interpretability of the model.

Major Results

The individual models achieved the following AUROC values:

| Model | Data Type | AUROC |
| ——————- | ———– | —— |
| EfficientNet-B1 | Chest X-ray | 0.7063 |
| EfficientNet-B2 | Chest X-ray | 0.6769 |
| Inception-ResNet-V2 | Chest X-ray | 0.6166 |
| Random Forest | EHR | 0.7980 |
| MLP | EHR | 0.8109 |
| XGBoost | EHR | 0.8352 |
| Ensemble Model | X-ray + EHR | 0.8698 |

The optimized ensemble model achieved:

  • AUROC: 0.8698
  • Accuracy: 0.86
  • Precision: 0.81
  • Recall: 0.74
  • F1-score: 0.77

These results demonstrate that combining chest X-ray images with electronic health records improved predictive performance compared with the individual models.

Advantages

  • Combines medical images and clinical data for better prediction.
  • Uses ensemble learning to improve performance.
  • Incorporates readily available clinical information.
  • Uses SHAP to explain the importance of clinical features.
  • Uses Grad-CAM to highlight relevant regions in chest X-ray images.
  • Optimizes the F1-score to address class imbalance.

Limitations

The dataset was relatively small, containing only 304 patients, and was imbalanced, with 68 non-survivors compared with 236 survivors. In addition, the study included patients with at least moderate COVID-19 severity, limiting the model’s generalizability to other patient populations.

Comparative Analysis of the Two Research Papers

The two studies demonstrate different applications of deep learning in healthcare. The first focuses on classifying Alzheimer’s disease using MRI scans, while the second predicts COVID-19 mortality using both medical images and clinical records.

| Parameter | Paper 1: Alzheimer’s Disease | Paper 2: COVID-19 Mortality |
| ——————– | ————————————————– | —————————————————— |
| Year | 2023 | 2023 |
| Journal | Journal of Medical Systems | BMC Bioinformatics |
| Main technique | EfficientNet-B0 CNN | Ensemble AI |
| Data type | MRI scans | Chest X-rays + EHR |
| Dataset size | 458 AD/sMCI scans + 245 CN scans | 304 patients |
| Main task | Disease classification | Mortality prediction |
| Validation | Five-fold cross-validation and external validation | Five-fold and 10-fold validation |
| Main metrics | Accuracy and AUC | AUROC and F1-score |
| Best reported result | 93.10% accuracy and 93% AUC | 0.8698 AUROC and 0.77 F1-score |
| Explainability | Occlusion sensitivity | SHAP and Grad-CAM |
| Major limitation | Limited dataset and similarity between AD and sMCI | Small, imbalanced dataset and limited generalizability |

The comparison shows that deep learning can support different healthcare tasks depending on the data and model architecture. While the first study demonstrates strong performance in MRI-based classification, the second shows that combining multiple data sources can improve mortality prediction.

Key Takeaways

  • Deep learning can automate medical image analysis and support disease classification.
  • Multimodal AI can combine medical images with clinical records to improve predictions.
  • Transfer learning and ensemble learning can improve model performance.
  • Explainability techniques such as SHAP, Grad-CAM, and occlusion sensitivity help researchers understand model decisions.
  • Larger datasets and broader clinical validation are necessary before deploying these models in real-world healthcare.

Research Gaps and Current Challenges

Despite promising results, several challenges remain in AI-based healthcare.

1. Limited Dataset Size

Both studies would benefit from larger datasets containing more diverse patients. Deep learning models generally require representative training data to achieve reliable performance across different clinical settings.

2. Need for External Validation

Models should be tested across multiple hospitals, countries, imaging devices, and patient populations. This would help determine whether their performance remains consistent outside the original research environment.

3. Multimodal AI Integration

Combining medical images, laboratory results, clinical history, and genetic information presents an opportunity to develop more comprehensive prediction systems. However, integrating different data types reliably remains a challenge.

4. Explainable Artificial Intelligence

Although the reviewed studies use interpretability techniques, understanding how AI models arrive at medical decisions remains important. Future systems should provide explanations that healthcare professionals can understand and verify.

5. Generalization and Reliability

Models trained on one patient population may not perform equally well on another. Differences in patient characteristics, imaging equipment, and clinical practices can affect performance.

6. Real-Time Clinical Implementation

High experimental accuracy alone is not sufficient for clinical deployment. AI systems must also meet requirements for patient safety, privacy, reliability, and integration into existing healthcare workflows.

Future Directions

Future research in AI-based healthcare can focus on the following areas:

  • Larger and more diverse datasets: Improve reliability across different patient populations.
  • Multimodal deep learning: Combine medical imaging, EHR data, laboratory results, and other clinical information.
  • Explainable AI: Make predictions easier for healthcare professionals to understand.
  • Federated learning: Enable collaborative model training while keeping sensitive patient data at participating institutions.
  • Transformer and foundation models: Explore advanced architectures for medical data analysis.
  • Real-time clinical decision support: Integrate AI predictions into healthcare workflows.
  • Personalized medicine: Develop models that account for individual patient characteristics.
  • Robustness and generalization: Improve performance across hospitals, imaging devices, and clinical environments.
  • Prospective clinical trials: Evaluate AI systems in real-world clinical settings before widespread adoption.

Conclusion

The reviewed research demonstrates the growing role of artificial intelligence and deep learning in healthcare. The first study uses EfficientNet-B0 and MRI data to classify Alzheimer’s disease and mild cognitive impairment, achieving a testing accuracy of 93.10% for the binary classification task. The second study combines CNN, MLP, XGBoost, and Random Forest models to predict COVID-19 mortality using chest X-rays and electronic health records, achieving an AUROC of 0.8698 and an F1-score of 0.77. The comparison highlights the potential of deep learning, ensemble learning, and multimodal AI to support medical diagnosis and prognosis. Techniques such as SHAP, Grad-CAM, and occlusion sensitivity can also help researchers understand the factors influencing model predictions. However, limitations involving dataset size, class imbalance, generalization, interpretability, and clinical validation remain significant challenges. Future research should focus on larger datasets, privacy-preserving learning, explainable models, and real-world clinical evaluation. Ultimately, AI should be viewed as a tool that supports healthcare professionals rather than replaces their judgment. With further research and validation, AI-based systems could contribute to earlier diagnosis, better-informed clinical decisions, and improved patient outcomes.

References

1. Agarwal, D., Berbís, M. Á., Luna, A., et al. (2023). Automated Medical Diagnosis of Alzheimer’s Disease Using an Efficient Net Convolutional Neural Network. Journal of Medical Systems, 47, 57. Springer. DOI: [10.1007/s10916-023-01941-4](https://doi.org/10.1007/s10916-023-01941-4?utm_source=chatgpt.com)

2. Baik, S. M., Hong, K. S., & Park, D. J. (2023). Deep learning approach for early prediction of COVID-19 mortality using chest X-ray and electronic health records. BMC Bioinformatics, 24, 190. Springer Nature. DOI: [10.1186/s12859-023-05321-0](https://doi.org/10.1186/s12859-023-05321-0?utm_source=chatgpt.com)

Publishing tip: In Blogger, create a new post, paste the content, and format the main title as the post title. Use Heading 2 for the main sections and Heading 3 for subsections. Add a medical AI cover image at the top, then click Preview to check how the blog looks before publishing.

Leave a Reply

Your email address will not be published. Required fields are marked *